Skip to main content
. 2011 Feb 1;54(5):1025–1031. doi: 10.1007/s00125-010-2025-0

Table 2.

Measures of glycaemic and blood pressure control at the baseline and at 4 and 8 years after the start of intervention

Variable Baseline 4 years after start of intervention 8 years after start of intervention
BMI (kg/m2) 23.0 ± 2.9 23.0 ± 3.0 23.0 ± 3.1
SBP (mmHg) 132.4 ± 15.8 132.5 ± 15.4 132.5 ± 15.9
DBP (mmHg) 76.6 ± 9.5 75.9 ± 9.1 74.0 ± 10.0
Fasting plasma glucose (mmol/l) 8.9 ± 2.4 8.9 ± 2.6 8.6 ± 2.5
HbA1c (%) 7.8 ± 1.3 7.7 ± 1.2 7.7 ± 2.0
Hypoglycaemic agent (%)
 Any use 84.4 89.3 86.6
 Insulin 20.7 30.1 41.9
 Sulfonylurea 62.3 63.3 59.7
 Alpha-glucosidase inhibitor 25.9 29.9 28.8
 Biguanide 7.5 16.1 32.8
 Insulin sensitiser 1.2 8.0 9.1
Antihypertensive agent (%)
 Any use 28.2 33.3 42.0
 ACE inhibitor/ARB 12.3 16.6 28.4
 Calcium-channel blocker 20.7 24.4 27.2
 Diuretic 1.2 1.1 2.9
 Other 6.0 7.1 8.6
Statin (%) 20.5 23.7 31.1

Each value is expressed as mean ± SD or percentage

DBP, diastolic blood pressure